Abbvie (ABBV) PT Raised to $140 at JPMorgan
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $164.66 --0%
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 16
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 16
Join SI Premium – FREE
JPMorgan analyst Chris Schott raised the price target on Abbvie (NYSE: ABBV) to $140.00 (from $135.00) while maintaining a Overweight rating.
You May Also Be Interested In
- FDA: working with AbbVie (ABBV) to identify, investigate and remove suspected counterfeit Botox products found in the US
- AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis
- Lithium Americas Corp. (LAC:CN) (LAC) PT Lowered to Cdn$5.10 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
